Distraction of rhBMP-2-Generated Mandible: How Stable Is the Engineered Bone in Response to Subsequent Surgeries?

Journal of Oral and Maxillofacial Surgery

Volumn 66, Issue 7, 2008, Pages 1499-1505

  Tom, William K ^a   Chin, Martin ^b   Ng, Theodore ^a   Bouchoucha, Slim ^a   Carstens, Michael ^c  

^a California Pacific Medical Center ^*

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ARTICLE; BONE DEVELOPMENT; CASE REPORT; CLEFT FACE; DISEASE CLASSIFICATION; DISTRACTION OSTEOGENESIS; FEMALE; HUMAN; HUMAN TISSUE; INFANT; MANDIBLE; MANDIBLE HYPOPLASIA; OSSIFICATION; OSTEOTOMY; RADIODIAGNOSIS; TISSUE ENGINEERING;

EID: 44949138328     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2007.12.011     Document Type: Article

References (4)

1. Chin M., Ng T., Tom W.K., et al. Repair of alveolar clefts with recombinant human bone morphogenetic protein (rhBMP-2) in patients with clefts. J Cranio Surg 16 (2005) 778
2. Boyne P.J., Lilly L.C., Marx R.E., et al. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Maxillofac Surg 63 (2005) 1693
3. Kuklo T.R., Bridwell K.H., and Cillo Y.A. Is there a clinically detectable response to repeat use of rhBMP-2 in the spine?. Proceedings of the NASS 22nd Annual Meeting. Spine J 7 (2007) IS-163S
4. Carstens M., Chin M., Ng T., et al. Reconstruction of #7 facial cleft with distraction-assisted in situ osteogenesis (DISO): Role of recombinant human bone morphogenetic protein-2 with helistat-activated collagen implant. J Cranio Surg 16 (2005) 1023